Setmelanotide
Setmelanotide is a synthetic peptide that targets the melanocortin-4 receptor (MC4R), a key regulator of appetite and energy balance. It has been studied for its ability to reduce hunger and support weight regulation in specific genetic forms of obesity. The compound is approved in certain clinical contexts but is also widely studied in metabolic research.
About the product
Setmelanotide is a cyclic peptide composed of eight amino acids with structural modifications that improve receptor selectivity and stability. Its design allows for strong and specific binding to the MC4R receptor. The cyclic structure enhances resistance to enzymatic degradation.
Setmelanotide activates the melanocortin-4 receptor in the hypothalamus, a brain region involved in appetite regulation. Activation of this receptor reduces hunger signals and can increase energy expenditure. This mechanism directly targets pathways involved in energy balance.
Setmelanotide is studied primarily for its role in regulating appetite and body weight. Clinical studies have shown reductions in hunger and body weight in individuals with specific genetic obesity disorders. Research also explores its broader applications in metabolic regulation.
Reported side effects include skin darkening, nausea, and injection-site reactions. Some individuals may experience changes in pigmentation due to activation of melanocortin receptors. Long-term safety is still being evaluated in ongoing studies.
Setmelanotide is synthesized using solid-phase peptide synthesis, where amino acids are assembled sequentially on a resin. The peptide is cyclized to form its stable structure, then purified using high-performance liquid chromatography. Mass spectrometry confirms identity and purity.
Setmelanotide has received regulatory approval for specific rare genetic obesity conditions. Outside of these indications, its use remains limited to approved medical contexts and ongoing research.
Clinical dosing varies depending on the condition and treatment protocol. Standardized dosing outside approved indications has not been established.
- Do follow approved clinical or research protocols.
- Do monitor metabolic and hormonal markers during studies.
- Don’t use outside approved indications or controlled research settings.
- Don’t combine with other appetite-regulating compounds without justification.
- Q: What receptor does setmelanotide target?
- A: It targets the melanocortin-4 receptor (MC4R).
- Q: What is it used for?
- A: It is used in specific genetic obesity conditions and studied in metabolic research.
- Q: Why can it affect skin color?
- A: It can activate related melanocortin receptors involved in pigmentation.
To guarantee authenticity and quality, we only sell through approved partners. Check our list of Verified Vendors to make sure you're buying the real thing.
Compound Overview
Related Peptides
